Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.

por Takanori Ikeda, Satoshi Ogawa, Takanari Kitazono, Jyoji Nakagawara, Kazuo Minematsu, Susumu Miyamoto, Yuji Murakawa, Sanghun Iwashiro, Yutaka Okayama, Toshiyuki Sunaya, Kazufumi Hirano, Takanori Hayasaki
Publicado 2021

Futile complete recanalization: patients characteristics and its time course

por Takaya Kitano, Kenichi Todo, Shinichi Yoshimura, Kazutaka Uchida, Hiroshi Yamagami, Nobuyuki Sakai, Manabu Sakaguchi, Hajime Nakamura, Haruhiko Kishima, Hideki Mochizuki, Masayuki Ezura, Yasushi Okada, Kazuo Kitagawa, Kazumi Kimura, Makoto Sasaki, Norio Tanahashi, Kazunori Toyoda, Eisuke Furui, Yuji Matsumaru, Kazuo Minematsu, Takeshi Morimoto
Publicado 2020

Author Correction: Time–outcome relationship in acute large-vessel occlusion exists across all ages: subanalysis of RESCUE-Japan Registry 2

por Kenichi Todo, Shinichi Yoshimura, Kazutaka Uchida, Hiroshi Yamagami, Nobuyuki Sakai, Haruhiko Kishima, Hideki Mochizuki, Masayuki Ezura, Yasushi Okada, Kazuo Kitagawa, Kazumi Kimura, Makoto Sasaki, Norio Tanahashi, Kazunori Toyoda, Eisuke Furui, Yuji Matsumaru, Kazuo Minematsu, Takaya Kitano, Shuhei Okazaki, Tsutomu Sasaki, Manabu Sakaguchi, Masatoshi Takagaki, Takeo Nishida, Hajime Nakamura, Takeshi Morimoto, RESCUE-Japan Registry 2 Investigators
Publicado 2021

Time–outcome relationship in acute large-vessel occlusion exists across all ages: subanalysis of RESCUE-Japan Registry 2

por Kenichi Todo, Shinichi Yoshimura, Kazutaka Uchida, Hiroshi Yamagami, Nobuyuki Sakai, Haruhiko Kishima, Hideki Mochizuki, Masayuki Ezura, Yasushi Okada, Kazuo Kitagawa, Kazumi Kimura, Makoto Sasaki, Norio Tanahashi, Kazunori Toyoda, Eisuke Furui, Yuji Matsumaru, Kazuo Minematsu, Takaya Kitano, Shuhei Okazaki, Tsutomu Sasaki, Manabu Sakaguchi, Masatoshi Takagaki, Takeo Nishida, Hajime Nakamura, Takeshi Morimoto, RESCUE-Japan Registry 2 Investigators
Publicado 2021